Co-Diagnostics, Inc. CORRESP, filed May 13, 2026: filename1.htm
CO-DIAGNOSTICS, INC.
May 13, 2026
VIA EDGAR
United States Securities and Exchange Commission
Division of Corporate Finance
100 F Street, N.E.
Washington, D.C. 20549
| Re: | Co-Diagnostics, Inc. — Registration Statement on Form S-3 (File No. 333-295803) |
Ladies and Gentlemen:
In accordance with Rule 461 under the Securities Act of 1933, as amended, we hereby request acceleration of the effective date of the Registration Statement on Form S-3 (File No. 333-295803) (the “Registration Statement”) of Co-Diagnostics, Inc. (the “Company”). We respectfully request that the Registration Statement be declared effective as of 5:00 p.m., Eastern Time, on May 15, 2026, or as soon as practicable thereafter. Once the Registration Statement has been declared effective, please orally confirm that event with our counsel, Dorsey & Whitney LLP, by calling Dan Lyman at (801) 933-4028.
Very truly yours,
| CO-DIAGNOSTICS, INC. | |
| /s/ Brian Brown | |
| Brian Brown | |
| Chief Financial Officer |